Recombinant multi-species IKBKG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IKBKG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the regulatory subunit of the inhibitor of kappaB kinase (IKK) complex, which activates NF-kappaB resulting in activation of genes involved in inflammation, immunity, cell survival, and other pathways. Mutations in this gene result in incontinentia pigmenti, hypohidrotic ectodermal dysplasia, and several other types of immunodeficiencies. A pseudogene highly similar to this locus is located in an adjacent region of the X chromosome. [provided by RefSeq, Mar 2016]
The Alternative Names of target: 1110037D23Rik,AMCBX1,EDAID1,FIP-3,FIP3,Fip3p,IKBKG,IKK-gamma,IKKAP1,IKKG,IKK[g],IMD33,IP,IP1,IP2,IPD2,IkB kinase subunit gamma),IkB kinase-associated protein 1 (IKKAP1),Ikbkg,Inhibitor of nuclear factor kappa-B kinase subunit gamma (I-kappa-B kinase subunit gamma,NEMO,NF-kappa-B essential modifier,NF-kappa-B essential modulator,Nemo,SAIDX,ZC2HC9

Target products collectionGo to IKBKG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13117-Ag-1/ GM-Tg-hg-IP13117-Ag-2 Human IKBKG protein Human
GM-Tg-rg-IP13117-Ag-1/ GM-Tg-rg-IP13117-Ag-2 Rat IKBKG protein Rat
GM-Tg-mg-IP13117-Ag-1/ GM-Tg-mg-IP13117-Ag-2 Mouse IKBKG protein Mouse
GM-Tg-cynog-IP13117-Ag-1/ GM-Tg-cynog-IP13117-Ag-2 Cynomolgus/Rhesus macaque IKBKG protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13117-Ag-1/ GM-Tg-felg-IP13117-Ag-2 Feline IKBKG protein Feline
GM-Tg-cang-IP13117-Ag-1/ GM-Tg-cang-IP13117-Ag-2 Canine IKBKG protein Canine
GM-Tg-bovg-IP13117-Ag-1/ GM-Tg-bovg-IP13117-Ag-2 Bovine IKBKG protein Bovine
GM-Tg-equg-IP13117-Ag-1/ GM-Tg-equg-IP13117-Ag-2 Equine IKBKG protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13117-Ag-1/ GM-Tg-hg-IP13117-Ag-2; GM-Tg-rg-IP13117-Ag-1/ GM-Tg-rg-IP13117-Ag-2;
GM-Tg-mg-IP13117-Ag-1/ GM-Tg-mg-IP13117-Ag-2; GM-Tg-cynog-IP13117-Ag-1/ GM-Tg-cynog-IP13117-Ag-2;
GM-Tg-felg-IP13117-Ag-1/ GM-Tg-felg-IP13117-Ag-2; GM-Tg-cang-IP13117-Ag-1/ GM-Tg-cang-IP13117-Ag-2;
GM-Tg-bovg-IP13117-Ag-1/ GM-Tg-bovg-IP13117-Ag-2; GM-Tg-equg-IP13117-Ag-1/ GM-Tg-equg-IP13117-Ag-2
Products Name IKBKG protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IKBKG
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IKBKG protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.